Key result
GWAS identify genetic loci linked to CAD risk, advancing novel treatments in lipid metabolism.
Design
Review
Authors
Loading...
May guide lipid-targeted CAD therapies; leaves open whether polygenic scores improve clinical risk stratification.
Key points are not available for this paper at this time.
Kessler et al. (2021) studied this question. Genome-wide association studies have identified numerous genetic loci associated with coronary artery disease risk, advancing novel treatments in lipid metabolism.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: